1. Home
  2. Analysis

Feeding tube complication and drugs of ingredients of gabapentin - a phase IV clinical study of FDA data


Summary:

Feeding tube complication is found among people who take drugs with ingredients of gabapentin, especially for people who are male, 2-9 old . This phase IV clinical study is created by eHealthMe based on reports of 363,277 people who have side effects when taking drugs with ingredients of gabapentin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Gabapentin, Gralise, Neurontin.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

363,277 people reported to have side effects when taking drugs with ingredients of gabapentin.
Among them, 6 people (0.0%) have Feeding tube complication

What is Feeding tube complication?

Feeding tube complication is found to be associated with 442 drugs and 201 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of gabapentin cause Feeding tube complication?

Gender of people who have Feeding tube complication when taking drugs with ingredients of gabapentin *:

  • female: 50 %
  • male: 50 %

Age of people who have Feeding tube complication when taking drugs with ingredients of gabapentin *:

  • 0-1: 0.0 %
  • 2-9: 50 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 0.0 %
  • 60+: 25 %

Conditions people have *:

  1. Swelling: 1 person, 16.67%
  2. Neuropathy Peripheral (surface nerve damage): 1 person, 16.67%
  3. Joint Pain: 1 person, 16.67%
  4. Immunodeficiency Common Variable: 1 person, 16.67%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 16.67%
  6. Gastric Disorder (disease of stomach): 1 person, 16.67%
  7. Diabetes: 1 person, 16.67%
  8. Depression: 1 person, 16.67%
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 16.67%
  10. Cardiac Disorder: 1 person, 16.67%

Other drugs people take *:

  1. Lorazepam: 2 people, 33.33%
  2. Nexium: 2 people, 33.33%
  3. Tylenol: 1 person, 16.67%
  4. Amlodipine Besylate: 1 person, 16.67%
  5. Cymbalta: 1 person, 16.67%
  6. Diastat: 1 person, 16.67%
  7. Diazepam: 1 person, 16.67%
  8. Dimetapp: 1 person, 16.67%
  9. Doxycycline: 1 person, 16.67%
  10. Famotidine: 1 person, 16.67%

Other side effects people have besides Feeding tube complication *:

  1. Diarrhea: 2 people, 33.33%
  2. White Blood Cell Count Increased: 1 person, 16.67%
  3. Breathing Difficulty: 1 person, 16.67%
  4. Lymphocyte Count Decreased: 1 person, 16.67%
  5. Hyperkalemia (damage to or disease of the kidney): 1 person, 16.67%
  6. Drug Toxicity: 1 person, 16.67%
  7. Drug Screen Positive: 1 person, 16.67%
  8. Drug Ineffective: 1 person, 16.67%
  9. Drug Dependence: 1 person, 16.67%
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drugs with ingredients of gabapentin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.